Gå direkt till innehåll

Pressmeddelande -

Sanofi-aventis: Results First quarter of 2006

First quarter of 2006: Sales growth of 9.6% on a reported basis and 4.9% on a comparable basis1 52.8% growth in adjusted EPS1 and 19.8% excluding selected items3 The consolidated income statement for the first quarter of 2006 is provided in the appendices. 2006 first-quarter consolidated net income came to €1,512 million, compared to €531 million for the first quarter of 2005, after the post-tax impact of the accounting treatment of the Aventis acquisition and restructuring costs (€661 million in Q1 2006, €884 million in Q1 2005). In order to give a better representation of our underlying economic performance, we have decided to publish and explain an adjusted consolidated income statement1 for the first quarter of 2006, and compare it with an adjusted income statement for the first quarter of 2005. Adjusted net income for the first quarter of 2006 amounted to €2,173 million, against €1,415 million for the first quarter of 2005.

Ämnen

Kontakter

Klara Kämpfer

Klara Kämpfer

Presskontakt Communications Business Partner (föräldraledig t.o.m. 08/2024)
Lovisa Fasth

Lovisa Fasth

Presskontakt Communications Business Partner

Sanofi är ett av världens ledande läkemedelsföretag

Sanofi är ett globalt, innovativt läkemedelsföretag

Sanofi

Franzéngatan 6
112 51 Stockholm
Sverige